NEEDLE, BIOPSY

The contract involves the procurement of 10-count packages of disposable Jamshidi bone marrow biopsy needles, NSN 6515-01-488-8392, with specifications including a 13-gauge tapered distal tip, 13.0-inch overall length, and standard handle, for delivery to the U.S. Naval Hospital Yokosuka, Japan. The solicitation under number SPE2DS-26-T-256P, posted on July 27, 2026, with a response deadline of July 30, 2026, operates under simplified acquisition procedures with a 20-day delivery requirement after award. Technical and quality mandates are governed by the DLA Master List of Technical and Quality Requirements, including RA001 for material controls, RP001 for packaging compliance, and RQ011 for removal of government identification from non-accepted supplies. Packaging and labeling must adhere to MIL-STD-2073-1E and Medical Marking Standard No. 1, superseding MIL-STD-129 except for radioactive materials, which still require MIL-STD-129 labeling. The item is subject to hazard communication standards, requiring proper labeling under OSHA’s Hazard Communication Standard and reference to applicable statutes such as FIFRA, FDCA, or CPSA where relevant. The contract incorporates multiple FAR and DFARS clauses covering employment eligibility verification, combating human trafficking, sustainable product compliance, safeguarding of covered contractor information systems, accelerated payments to small business subcontractors, and system for award management maintenance. Offerors must represent their small business status and socioeconomic certifications, including WOSB, EDWOSB, SDVOSB, and HUBZone eligibility, and provide UEI and CAGE codes if supplying covered defense telecommunications equipment. All deliveries are FOB destination with government inspection and acceptance at the delivery point. Invoicing must occur via Wide Area WorkFlow (WAWF), and compliance with DFARS clauses including NIST SP 800-171 assessment requirements and subcontracting rules for commercial items is mandatory. No contract value is stated, and pricing details are not provided, indicating a price-driven award likely under simplified acquisition rules. The contracting officer is Katy Recinos, with oversight coordinated through the Medical Supply Chain MD Surg FSF under the Department of Defense.